{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:31:50Z","timestamp":1778643110160,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.parkreldis.2021.08.019","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:06:57Z","timestamp":1630548417000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients"],"prefix":"10.1016","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4101-1454","authenticated-orcid":false,"given":"Elze R.","family":"Timmers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn","family":"van Faassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marenka","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2166-4095","authenticated-orcid":false,"given":"Anouk","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid H.","family":"Hof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ido P.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina A.J.","family":"Tijssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klary E.","family":"Niezen-Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom J.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.08.019_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"28","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101678","article-title":"Dystonia and dopamine: from phenomenology to pathophysiology","volume":"182","author":"Ribot","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib3","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/mds.23709","article-title":"Nonmotor manifestations of dystonia: a systematic review","volume":"26","author":"Kuyper","year":"2011","journal-title":"Mov. Disord."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.08.019_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-6394(2000)12:1+<2::AID-DA2>3.0.CO;2-4","article-title":"Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders","volume":"12","author":"Ressler","year":"2000","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.parkreldis.2021.08.019_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2021.08.019_bib6","first-page":"4","article-title":"The neurotransmitters of sleep","volume":"65","author":"Siegel","year":"2004","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neubiorev.2016.03.015","article-title":"Serotonergic perturbations in dystonia disorders-a systematic review","volume":"65","author":"Smit","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.parkreldis.2019.10.015","article-title":"Myoclonus-dystonia: distinctive motor and non-motor phenotype from other dystonia syndromes","volume":"69","author":"Timmers","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00259-017-3664-x","article-title":"The relationship between the dopaminergic system and depressive symptoms in cervical dystonia","volume":"44","author":"Zoons","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101678","article-title":"Dystonia and dopamine: from phenomenology to pathophysiology","volume":"182","author":"Ribot","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00259-008-0924-9","article-title":"Reduced striatal D2 receptor binding in myoclonus-dystonia","volume":"36","author":"Beukers","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib12","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1373\/clinchem.2019.305359","article-title":"Quantitative profiling of platelet-rich plasma indole markers by direct-matrix derivatization combined with LC-MS\/MS in patients with neuroendocrine tumors","volume":"65","author":"van Faassen","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib13","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1021\/acs.analchem.0c01263","article-title":"In matrix derivatization combined with LC-MS\/MS results in ultrasensitive quantification of plasma free metanephrines and catecholamines","volume":"92","author":"van Faassen","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.nbd.2019.01.012","article-title":"Trihexyphenidyl rescues the deficit in dopamine neurotransmission in a mouse model of DYT1 dystonia","volume":"125","author":"Downs","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib15","first-page":"414","article-title":"Dopa-responsive dystonia--clinical and genetic heterogeneity","volume":"11","author":"Wijemanne","year":"2015","journal-title":"Nat. Rev."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.parkreldis.2012.08.016","article-title":"Cervical dystonia and genetic common variation in the dopamine pathway","volume":"19","author":"Groen","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1478-811X-11-34","article-title":"Complexity of dopamine metabolism","volume":"11","author":"Meiser","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/B978-0-12-381326-8.00003-X","article-title":"Distribution and functions of catechol-O-methyltransferase proteins. Do recent findings change the picture?","author":"My\u00f6h\u00e4nen","year":"2010","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib19","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00702-010-0562-9","article-title":"Transcriptional regulation and multiple functions of MAO genes","volume":"118","author":"Shih","year":"2011","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jnr.490060310","article-title":"Cathechol-O-methyltransferase activity in cultured human skin fibroblasts from controls and patients with dystonia musculorum deformans","volume":"6","author":"Breakefield","year":"1981","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(87)90056-4","article-title":"CSF amine metabolites and depression","volume":"21","author":"Peabody","year":"1987","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.euroneuro.2005.12.002","article-title":"Dopaminergic-based pharmacotherapies for depression","volume":"16","author":"Papakostas","year":"2006","journal-title":"Eur. Neuropsychopharmacol"},{"key":"10.1016\/j.parkreldis.2021.08.019_bib23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","article-title":"Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment","volume":"8","author":"Chaudhuri","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib24","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1006\/bbrc.1995.2180","article-title":"Exon skipping caused by a base substitution at a splice site in the GTP cyclohydrolase I gene in a Japanese family with hereditary progressive dystonia dopa responsive dystonia","volume":"213","author":"Hirano","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ng1194-236","article-title":"Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene","volume":"8","author":"Ichinose","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.10175","article-title":"Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia","volume":"51","author":"Furukawa","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10522-012-9406-3","article-title":"Serotonin: from top to bottom","volume":"14","author":"Fidalgo","year":"2013","journal-title":"Biogerontology"},{"key":"10.1016\/j.parkreldis.2021.08.019_bib28","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0893-133X(02)00361-5","article-title":"Predictors of mood response to acute tryptophan depletion: a reanalysis","volume":"27","author":"Booij","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.parkreldis.2021.08.019_bib29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/nu8010056","article-title":"Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain Axis","volume":"8","author":"Jenkins","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.parkreldis.2021.08.019_bib30","doi-asserted-by":"crossref","first-page":"559","DOI":"10.2174\/1570159X15666170915141036","article-title":"The microbiota-gut-brain Axis in neuropsychiatric disorders: pathophysiological mechanisms and novel treatments","volume":"16","author":"Kim","year":"2018","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib31","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3389\/fneur.2019.00574","article-title":"The gut and Parkinson's disease-A bidirectional pathway","volume":"10","author":"Santos","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib32","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/0006-3223(85)90176-3","article-title":"Obsessive-compulsive disorder and serotonin: is there a connection?","volume":"20","author":"Insel","year":"1985","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib33","article-title":"Cerebellar 5HT-2A receptor mediates stress-induced onset of dystonia","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib34","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2020.11.020","article-title":"A metabolomic study of cervical dystonia","volume":"82","author":"Liu","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib35","first-page":"64","article-title":"The utility of CSF for the diagnosis of primary and secondary monoamine neurotransmitter deficiencies","volume":"28","author":"Burlina","year":"2017","journal-title":"EJIFCC"},{"key":"10.1016\/j.parkreldis.2021.08.019_bib36","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","article-title":"Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors","volume":"94","author":"de Jong","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib37","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/0004563215613109","article-title":"Serum and plasma 5-hydroxyindoleacetic acid as an alternative to 24-h urine 5-hydroxyindoleacetic acid measurement","volume":"53","author":"Adaway","year":"2016","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.parkreldis.2021.08.019_bib38","doi-asserted-by":"crossref","first-page":"12675","DOI":"10.1038\/s41598-020-69559-x","article-title":"The relationship between blood metabolites of the tryptophan pathway and kidney function: a bidirectional Mendelian randomization analysis","volume":"10","author":"Cheng","year":"2020","journal-title":"Sci. Rep."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021003138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:23:15Z","timestamp":1761178995000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021003138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":38,"alternative-id":["S1353802021003138"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.08.019","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dopaminergic and serotonergic alterations in plasma in three groups of dystonia patients","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.08.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}